REL-1017 by Relmada Therapeutics: A NMDA Receptor Antagonists – Global Emerging Insight and Market Forecast Report 2021-2030 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “REL-1017 – Emerging Insight and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.
REL-1017 acts as NMDA receptor antagonists and is being developed Relmada Therapeutics. The U.S. Food and…